首页> 外文期刊>Archives of virology >Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments.
【24h】

Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments.

机译:牛痘病毒载体产生的重组蛋白可以在病毒体(IMV形式)内并入不同的区室。

获取原文
获取原文并翻译 | 示例
           

摘要

Vaccinia virus (VV) is one of the largest and most complex of animal viruses, with a virion that contains about 100 different polypeptides. Assembly of the viral proteins occurs in discrete cytoplasmic sites leading to formation of two infectious forms, an abundant (>90%) intracellular mature virus (IMV) with an envelope, and a minor extracellular enveloped virus (EEV) with an extra membrane acquired from the trans-Golgi network. It has been shown that while EEV contains in the outer membrane cellular proteins probably acquired during virus release from cells, however, IMV exclude host proteins during assembly. Since VV recombinants (VVr) expressing genes of interest are candidates as potential vaccines against pathogens and cancer, it becomes important to know if VVr can acquire foreign proteins during morphogenesis. In this investigation we show that purified virions (IMVs) from VVr can incorporate foreign proteins into different sites in the virus particle. By sequential fractionation of virion compartments with detergents, we found foreign proteins in the lipid envelope (cytokine IL-12 and CS antigen of Plasmodium yoelii), as part of a protein matrix-like membrane (HIV-1 gp41 of env), or more closely associated with the core containing the DNA complexes (HIV-1 gp160; a multiepitopic protein with the V3 loop of HIV-1 Env from different isolates, and beta-galactosidase). Similar findings were observed with purified virions derived from the WR strain as well as from the highly attenuated modified vaccinia virus Ankara (MVA) strain. These observations should be taken into consideration when VVr are used in clinical trials or in other vaccination approaches.
机译:牛痘病毒(VV)是最大,最复杂的动物病毒之一,其病毒粒子包含约100种不同的多肽。病毒蛋白的组装发生在离散的细胞质部位,导致形成两种感染形式,一种是带有包膜的丰富的(> 90%)细胞内成熟病毒(IMV),另一种是带有额外膜的小细胞外包膜病毒(EEV),跨高尔基网络。已经显示,尽管EEV在外膜中包含可能在病毒从细胞释放期间获得的细胞蛋白,但是,IMV在组装过程中排除了宿主蛋白。由于表达目的基因的VV重组体(VVr)可以作为抗病原体和癌症的潜在疫苗,因此了解VVr是否可以在形态发生过程中获得外源蛋白质就变得很重要。在这项研究中,我们显示了来自VVr的纯化病毒体(IMV)可以将外源蛋白质掺入病毒颗粒的不同位点。通过用洗涤剂顺序分离病毒粒子区室,我们发现脂质包膜(约氏疟原虫的细胞因子IL-12和CS抗原)中的外源蛋白质,是蛋白质基质样膜(env的HIV-1 gp41)的一部分,或更多与含有DNA复合物(HIV-1 gp160;具有来自不同分离株的HIV-1 Env的V3环的V3环和β-半乳糖苷酶)的核心紧密相关。从WR菌株以及高度减毒的改良痘苗病毒安卡拉(MVA)菌株获得的纯化病毒体也观察到了类似的发现。在临床试验或其他疫苗接种方法中使用VVr时,应考虑这些观察结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号